High Court Nixes Allergan Appeal Of Generic Latisse IP Case
The U.S. Supreme Court on Monday refused to hear an appeal by Allergan Inc. of a Federal Circuit decision that deemed two patents covering eyelash growth stimulant Latisse invalid and lifted...To view the full article, register now.
Already a subscriber? Click here to view full article